A carregar...
A Review of the First Year of Medicare Coverage of Erythropoietin
Recombinant human erythropoietin (rHuEPO) is a new drug for treating anemia associated with end stage renal disease (ESRD). In a study of rHuEPO diffusion, costs, and effectiveness, we analyze ESRD program data and all claims submitted to Medicare for reimbursement of rHuEPO administered to ESRD dia...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
CENTERS for MEDICARE & MEDICAID SERVICES
1994
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4193448/ https://ncbi.nlm.nih.gov/pubmed/10137799 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|